These results, together with a preceding report demonstrating that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,2 support the idea of focusing on ACKR3 as a novel method to modulate the opioid program, which could open new therapeutic avenues for opioid-similar Diseases. At that point, Microsoft Advertising https://richardb382hgb4.iamthewiki.com/user